Paid Clinical Trials in Greensboro, NC
As of August 2026, 109 paid clinical trials are recruiting in Greensboro, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Greensboro offers studies at sites including Cone Health Cancer Center for conditions such as Obesity, Overweight, Malignant Solid Neoplasm, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Greensboro
Trials by drug in Greensboro
Filter results
Newly added in Greensboro
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
97 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Prevail Global Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Top Research Study Locations in Greensboro
Researchers run research studies in Greensboro, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cone Health Cancer Center | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 18 |
| Cone Health Cancer Center at Drawbridge Parkway | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 13 |
| Headache Wellness Center | Acute Migraine, Acute Treatment of Migraine, Migraine | 6 |
| Medication Management | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 5 |
| Moses H. Cone Memorial Hospital | Heart Failure, Acute Decompensated Heart Failure, Atrial Enlargement | 4 |
| Novant Health Breast Surgery - Greensboro | Breast Cancer, Cigarette Smoking-Related Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma | 4 |
| Carolina Kidney Associates | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Focal Segmental Glomerulosclerosis, Kidney Disease, Chronic | 3 |
| Medication Management LLC | Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Obesity | 3 |
| PharmQuest | Diabetes Mellitus, Type 2, Obesity, Overweight | 3 |
| PharmQuest Life Sciences LLC | Obesity, Overweight, Type 2 Diabetes | 3 |
| Triad Clinical Trials | Alzheimers Disease, Tophaceous Gout | 3 |
| Pulmonix LLC | Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interstitial Lung Disease | 3 |
| GSK Investigational Site | HIV Infections | 2 |
| Medication Mgmnt, LLC_Grnsboro | Obesity, Overweight | 2 |
| Moses H Cone Memorial Hospital | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Obesity | 2 |
| Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health | Heart Failure, Heart Failure With Reduced Ejection Fraction, Moderate Aortic Valve Stenosis | 2 |
| PulmonIx, LLC | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Cancer | 2 |
| Triad Clinical Trials, LLC | Cardiovascular Disease, Uncontrolled Gout | 2 |
| UNC Greensboro | Active Citizenship, Aerobic Exercise, Anti-extremism | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 2 |
| Regional Center for Infectious Diseases | HIV Pre-Exposure Prophylaxis, Human Immunodeficiency Virus (HIV), Human Immunodeficiency Virus Type 1 (HIV-1) Infection | 2 |
| 3203 Greensboro CRS | HIV Infection, Menopause | 1 |
| 3203, Greensboro CRS | Acute HIV Infection | 1 |
| Clinical Research | Severe Hypertriglyceridemia | 1 |
| Cone Health | Breastfeeding Continuation, Breastfeeding Duration, Breastfeeding Self-Efficacy | 1 |
Active & Upcoming Studies in Greensboro (2026)
Recruiting trials in Greensboro grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors · Phase 3 · SWOG Cancer Research Network
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Diabetes & metabolic (17 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
Cardiovascular (12 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- Low Energy Availability and Hypertension in Division I HBCU Athletes · North Carolina Agriculture & Technical State University
Neurology & pain (8 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
HIV / STI (6 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Eye & vision (2 active studies)
- Post-refractive IOL Outcomes With Clareon TruPlus · Laser Defined Vision
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Common conditions studied in Greensboro
- Obesity (12 active studies)
- Overweight (9 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Heart Failure (4 active studies)
- Breast Cancer (3 active studies)
- Interstitial Lung Disease (3 active studies)
Leading research sponsors in Greensboro
- Novo Nordisk A/S
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Greensboro?
There are approximately 109 recruiting clinical trials in Greensboro, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Greensboro pay participants?
Most recruiting trials in Greensboro compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Greensboro?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Greensboro?
The most common conditions under active study in Greensboro include Obesity (12), Overweight (9), Malignant Solid Neoplasm (5), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Greensboro?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Greensboro on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Greensboro?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Greensboro?
Recruiting research sites in Greensboro include Cone Health Cancer Center, Cone Health Cancer Center at Drawbridge Parkway, Headache Wellness Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Greensboro right now?
The largest active categories in Greensboro are Cancer & tumors (21), Diabetes & metabolic (17), Cardiovascular (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.